← Back to Investor Relations
In the Press
Quest Diagnostics to Offer Liver Cancer Blood Test
Why This Matters
NewsBreak's 13.9 million monthly visitors demonstrate how industry trade coverage in Becker's ASC Review gets amplified through major news aggregation platforms, extending Helio's reach far beyond the original clinical audience.
Article Summary
NewsBreak syndicated the Becker's ASC Review article announcing that Quest Diagnostics will offer HelioLiver through its nationwide network starting April 2026. The syndication amplified the story from Becker's clinical audience to NewsBreak's 13.9 million monthly visitors, demonstrating how top-tier news platforms rely on industry trade media to credential stories in cancer diagnostics.